Showing 1–20 of 250 alerts
Food Recall
2026 record
Source: FDA
Saint Francis Apizza LLC Recall initiated
October 1, 2026 Reported by FDA
October 14, 2026
View Details
Food Recall
2026 record
Source: FDA
Saint Francis Apizza LLC Recall initiated
October 1, 2026 Reported by FDA
October 14, 2026
View Details
Food Recall
2026 record
Source: FDA
Saint Francis Apizza LLC Recall initiated
October 1, 2026 Reported by FDA
October 14, 2026
View Details
Food Recall
2026 record
Source: FDA
Saint Francis Apizza LLC Recall initiated
October 1, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05 Recall initiated
September 28, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-0. Recall initiated
September 25, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Product of Canada, NDC 16714-249-02. Recall initiated
September 25, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-9. Recall initiated
September 25, 2026 Reported by FDA
October 14, 2026
View Details
Food Recall
2026 record
Source: FDA
Pepsico Inc Recall initiated
September 25, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06. Recall initiated
September 24, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18. Recall initiated
September 24, 2026 Reported by FDA
October 14, 2026
View Details
Food Recall
2026 record
Source: FDA
GIAS FOOD INC. Recall initiated
September 24, 2026 Reported by FDA
October 14, 2026
View Details
Food Recall
2026 record
Source: FDA
Galil Importing Corp Recall initiated
September 24, 2026 Reported by FDA
October 7, 2026
View Details
Drug Recall
2026 record
Source: FDA
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01 Recall initiated
September 23, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3 Recall initiated
September 23, 2026 Reported by FDA
October 7, 2026
View Details
Food Recall
2026 record
Source: FDA
G L Mezzetta Inc Recall initiated
September 19, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67. Recall initiated
September 18, 2026 Reported by FDA
October 14, 2026
View Details
Drug Recall
2026 record
Source: FDA
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19 Recall initiated
September 17, 2026 Reported by FDA
October 7, 2026
View Details
Drug Recall
2026 record
Source: FDA
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02 Recall initiated
September 17, 2026 Reported by FDA
October 7, 2026
View Details
Food Recall
2026 record
Source: FDA
QUESO PALMITA GP LLC Recall initiated
September 15, 2026 Reported by FDA
October 14, 2026
View Details
Data last updated: October 23, 2026 ET
Investigations and recalls may be ongoing; status, case counts, and guidance are updated by the source agency as events continue.
Read the full medical disclaimer .
Explore more